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RESUmEn 
Objetivo: Evaluar el efecto del pre condi-
cionamiento con sinvastatina en la insufi-
ciencia renal aguda inducida por sepsis. 
Método: Ratas Wistar, adultas, machos, 
fueron distribuidos en los grupos: SHAM 
(control); SHAM+Estatina (0,5 mg/kg sin-
vastatina, vía oral); Sepsis (ligadura y pun-
ción cecal – LPC); Sepsis+Estatina. Fueron 
evaluados los parámetros fisiológicos, la 
cultura de líquido peritoneal, la función re-
nal, los metabolitos oxidativos, la severidad 
de la insuficiencia renal aguda y la supervi-
vencia de los animales. Resultados: El tra-
tamiento con sinvastatina en la sepsis indu-
cida demostró elevación del aclaramiento 
de creatinina con atenuación de la genera-
ción de los metabolitos oxidativos, menor 
severidad del fallo renal agudo y reducción 
del índice de mortalidad. Conclusión: Esta 
investigación confirmó la renoprotección 
con principio antioxidante de la sinvastati-
na en el fallo renal agudo inducido por la 
sepsis en modelo experimental.    
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RESUmo 
Objetivo: Avaliar o efeito do pré-condi-
cionamento com sinvastatina na lesão 
renal aguda induzida por sepse. Método: 
Ratos Wistar, adultos, machos foram dis-
tribuídos nos grupos: SHAM (controle); 
SHAM+Estatina (0,5 mg/kg sinvastatina, 
via oral); Sepse (ligadura punção de cé-
cum – LPC); Sepse+Estatina. Foram avalia-
dos parâmetros fisiológicos, cultura líqui-
do peritoneal, função renal, metabólitos 
oxidativos, gravidade da lesão renal aguda 
e sobrevida dos animais. Resultados: O 
tratamento com sinvastatina na sepse in-
duzida demonstrou elevação do clearance 
de creatinina com atenuação da geração 
dos metabólitos oxidativos, menor gravi-
dade da lesão renal aguda e redução da 
taxa de mortalidade. Conclusão: Esta in-
vestigação confirmou a renoproteção com 
princípio antioxidante da sinvastatina na 
lesão renal aguda induzida pela sepse em 
modelo experimental. 
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AbStRAct 
Objective: Evaluating the effect of pre-
conditioning with simvastatin in acute 
kidney injury induced by sepsis. Method: 
Male adult Wistar rats were divided into 
the following groups: SHAM (control); 
SHAM+Statin (0.5 mg/kg simvastatin, 
orally); Sepsis (cecal puncture ligation 
– CPL); Sepsis+Statin. Physiological pa-
rameters, peritoneal fluid culture, renal 
function, oxidative metabolites, severity 
of acute kidney injury and animal survival 
were evaluated. Results: The treatment 
with simvastatin in induced sepsis showed 
elevation of creatinine clearance with at-
tenuation of generation of oxidative me-
tabolites, lower severity of acute kidney 
injury and reduced mortality. Conclusion: 
This investigation confirmed the renopro-
tection with antioxidant principle of the 
simvastatin in acute kidney injury induced 
by sepsis in an experimental model.
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intRodUction
Sepsis is the leading cause of death in the intensive 
care unit (ICU)(1). In Brazil, a multicenter study carried 
out in ICUs showed that 16.7% of patients were diagno-
sed with sepsis, severe sepsis or septic shock, and the 
described mortality rate was 46.6%(2).
In sepsis, the first line of host defense, the innate im-
munity, is developed by phagocytic cells (macrophages, 
monocytes, granulocytes, polymorphonuclear cells), 
followed by endotoxins of gram-negative bacteria and 
mainly the lipid A and teichoic acid from gram-positive 
bacteria that activate immunoglobulins and induce a 
specific or acquired immune response, with the release 
of primary inflammatory mediators. This cellular reaction 
triggers an excessive inflammatory response with relea-
se of secondary mediators, including cytokines, comple-
ment factors, the prostanoids, the activation of platelet 
aggregating factor (PAF) and the generation of reactive 
oxygen species (ROS)(3). These functional changes induce 
thrombosis of the microvasculature with hypercoagula-
bility by fibrin deposits, evolving to a condition of dis-
seminated intravascular coagulation (DIC), especially in 
cases of severe sepsis and septic shock(4).
In kidneys, the induction of inflammatory processes 
and the generation of ROS activate the coagulation cas-
cade in the renal microvasculature, resulting in a state 
of hypoxia and hypotension. The increased ROS genera-
tion is observed, which directly interferes with the cell 
signaling cascade and exerts deleterious effects on renal 
tubule cells, highlighting the lipid peroxidation of the cell 
membrane, protein oxidation and DNA damage(5-6). The 
vasoconstrictor predominance results in decreased renal 
blood flow (RBF) hence, reduces the glomerular filtration 
rate (GFR)(5) and unbalances the excretion of electrolytes 
and water, with accumulation of nitrogenous metaboli-
tes such as urea and creatinine(7). The systemic increase 
of these compounds establishes the clinical diagnosis of 
acute kidney injury (AKI)(8).
In the clinic, the AKI is characterized as abrupt reduc-
tion in kidney function, with increase in the absolute value 
of serum creatinine, equal to or higher than 0.3 mg/dl or 
increased 1.5 times or more, compared with baseline cre-
atinine or yet, the urinary volume lower than 0.5 ml/kg/h 
for six hours or more(8). The occurrence of AKI drastically 
increases the mortality profile of the patient with sepsis.
Considering the particularities of sepsis-induced AKI, 
it is extremely important to analyze all its variables, and 
seek possibilities to interfere in complications. In this 
context, the pharmacological interventions that reduce 
the mechanism of oxidative damage in sepsis stand out. 
Among the alternatives, statins have been investigated 
for their pleiotropic actions, i.e., not lipid-lowering. Sta-
tins are anti-inflammatory(9), antioxidant(10-11), immuno-
modulatory(12), antiproliferative(9), antithrombotic and 
with action of endothelial protection(11). Data from expe-
rimental models in vitro, in vivo and clinical studies sug-
gest that statins are potentially beneficial agents in the 
condition of sepsis-induced AKI.
Thus, the objective of this study was to evaluate the 
effect of preconditioning with simvastatin in animals wi-
th sepsis-induced AKI. 
mEtHod
The procedures for this study are in accordance with the 
ethical principles for animal experimentation adopted by the 
Colégio Brasileiro de Experimentação Animal (COBEA). The 
study was approved by the Ethics Committee in Animal Ex-
periments of the Faculty of Medicine, Universidade de São 
Paulo (CEUA-FMUSP), under protocol number 378/13. 
Animals: Male Wistar rats, weighing between 250 and 
350 g. The animals were kept in collective cages with free 
access to water and food in thermal conditions, with alter-
nating cycles of day and night.
The animals were divided into the following groups: 
SHAM (sepsis control) - the animals underwent laparo-
tomy with cecal manipulation and received fluid resus-
citation of 25 ml/kg of sodium chloride 0.9%, which was 
administered intraperitoneally (i.p.) at the end of the CPL 
(cecal puncture ligation) procedure in the sixth, eighth, 
and 24th hours of the postoperative period(13); SHAM + 
Statin – the animals were preconditioned with 0.5 mg/kg 
of simvastatin by gavage (p.o.) for five days, once a day(14) 
and underwent laparotomy (cecal manipulation), with 
start of fluid resuscitation; Sepsis - the animals were anes-
thetized with ketamine / xylazine (75 mg/kg / 10mg/kg) 
intraperitoneally and underwent laparotomy for comple-
ting the CPL procedure with fluid resuscitation; Sepsis + 
Statin - the animals were pretreated with simvastatin for 
five days and submitted to CPL and fluid resuscitation.
Metabolic cage: A day (24 hours) after surgery, the 
animals were placed in individual metabolic cages for 
24-hour urine collection for evaluation of renal function 
and oxidative metabolites.
Physiological parameters: At the end of the 24-hour pe-
riod, the animals were anesthetized with thiopental sodium 
(100 mg/kg) i.p., for evaluation of rectal temperature with 
a Premium Oval® clinical thermometer of mercury column. 
Then, a small sample of tail blood of the animal was collected 
to evaluate blood glucose with the Accu-Chek Active®. 
Culture of peritoneal fluid: 2 ml of peritoneal fluid we-
re collected in laminar flow cabinet using aseptic technique, 
transferred to a test tube with culture medium supplemen-
ted with TSB (Tryptic Soy Broth, Bacto™ BD, Lot. 2206180), 
and remained incubated in an oven for 14 days at approxi-
mate temperature of 37 ° C. Readings were done in the pe-
riods of 72 hours, seven days and 14 days for checking the 
turbidity of extract(15).
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Whole-blood collection: The whole blood collection 
was carried out by puncture of the abdominal aorta and 
subsequent evaluation of renal function.
Renal function: It was evaluated by creatinine clearan-
ce. The colorimetric Jaffé method was used to determine 
the values of serum and urinary creatinine. Creatinine cle-
arance was calculated by the formula: creatinine clearance 
= urine creatinine x urine output 24h / serum creatinine(16). 
Urinary peroxides: It was carried out with the FOX-2 
method, by the use of orange iron-xylenol, which oxidizes 
Fe2+ and produces a purplish-blue color complex (α= 4.3 
x 104 M-1 cm-1)(17).
Urinary TBARS: Allows the evaluation of the cascade end 
products of lipid peroxidation which react in the presence of 
thiobarbituric acid in body fluids (α= 1.56 x 105 M-1 cm-1)(18).
Severity of AKI and survival curve: The severity of AKI 
was classified according to serum creatinine and the AKIN 
criteria (Acute Kidney Injury Network). By this criterion, 
the AKI can be classified into three stages: the AKIN stage 
1, in which is observed the increase of 0.3 mg/dl, or of 
one to two times the baseline serum creatinine value, or 
urine output less than 0.5 ml/kg/h for 6 hours; AKIN stage 
2, where there is an increase of two to three times the ba-
seline serum creatinine value, and urine output less than 
0.5 mL/kg/h for 12 hours; the AKIN stage 3, which repre-
sents an increase of more than three times the baseline 
serum creatinine value, or urine output less than 0.3 mL/
kg/h for 24 hours(8). The survival rate was analyzed by the 
adaptation of the Kaplan-Meier curve(19). 
Statistics: The variance between groups was analyzed by 
One Way ANOVA test, followed by the Newman-Keuls mul-
tiple comparison post-test of the Graph-Pad Prism version-3 
for Windows®. Values of p<0.05 were considered significant. 
RESUltS
Body temperature and blood glucose
Table 1 shows that Sepsis and Sepsis + Statin groups sho-
wed significant reduction in body temperature and elevated 
blood glucose compared to the SHAM and SHAM + Statin 
groups (p<0.001).  
Table 1 - Results related to body temperature and blood glucose 
of various groups - São Paulo, 2013.
Grupos N Temperature (ºC) Glycemia (mg/dl)
SHAM 8 36.7±0.6 106.9±8.4
SHAM + Statin 8 36.4±0.3 107.9±8.3
Sepse 8 34.8±0.6ab 299.0±7.2ab
Sepse + Statin 8 35.1±0.4ab 300.3±9.3ab
ap < 0,001 vs SHAM.
bp < 0,001 vs SHAM + Statin.
Data show mean ± standard deviation
Table 2 - Results related to global renal function of various groups - São Paulo, 2013
Grupos N Urinary Output (ml/ min) Urine Cr (mg/dl) Serum Cr (mg/dl) Crcl/ 100g (ml/ min)
SHAM 8 0.015 ± 0.003 57,66 ± 17.5 0.32 ± 0.08 0.85 ± 0.08
SHAM + Statin 8 0.014 ± 0.002 58,06 ± 12.5 0.35 ± 0.08 0.83 ±0.09
Sepse 8 0.007 ± 0.003ab 99,52 ± 37.3 0.93 ± 0.11ab 0.22 ± 0.07ab
Sepse + Statin 8 0.009 ± 0.002ab 49,82 ± 16.1 0.41 ± 0.10ac 0.46 ± 0.08abc
Note: Cr – creatinine, Crcl –creatinine clearance.
ap < 0.05 vs SHAM.
bp < 0.05 vs SHAM + Statin.
cp < 0.05 vs Sepse.
Data show mean ± standard deviation.
Culture of peritoneal fluid
O grupo SHAM apresentou resultado negativo para o 
crescimento de micro-organismo, verificado pela ausência 
de alterações no extrato em 72 horas, sete dias e 14 dias 
de incubação. Por outro lado, o grupo Sepse apresentou 
resultado positivo para cultura do líquido peritoneal com 
turvação do extrato em 72 horas, sete dias e 14 dias de 
incubação.
Renal function
A Table 2 shows that animals which suffered induction 
of sepsis showed a significant reduction in urinary output, 
elevated serum creatinine, and consequent reduction in 
creatinine clearance (p<0.05). In contrast, it was found 
that preconditioning with simvastatin in septic animals 
significantly reduced the level of serum creatinine, resul-
ting in elevation of creatinine clearance in relation to the 
Sepsis group (p<0.05), with maintenance of urine output 
when compared with Sepsis animals.
Urinary peroxides and TBARS
Table 3, shows that the Sepsis group showed an in-
crease in the excretion of urinary peroxides when com-
pared to the SHAM and SHAM+Statin groups (p<0.001). 
The Sepsis+Statin group demonstrated significant re-
duction of urinary peroxides in relation to the Sepsis 
group (p<0.001). 
Regarding urinary TBARS, it was found that the Sepsis 
group had higher levels of this metabolite compared with 
the SHAM and SHAM+Statin groups (p<0.001). The precon-
ditioning with simvastatin significantly reduced the TBARS 
levels in septic animals (p< 0.001).
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Table 3- Results related to the values of urinary peroxides and 
TBARS of various groups - São Paulo, 2013.
Groups N Urinary peroxides  (nmol/g of UCr)
Urinary TBARS   
(nmol/g of UCr)
SHAM 8 5.3 ± 1.3 219.5 ± 22.7
SHAM + Statin 8 6.2 ± 2.7 200.6 ± 26.3
Sepse 8 20.3 ± 5.8ab 945.6 ± 26.9ab
Sepse + Statin 8 11.6 ± 3.8abc 616.8 ± 25.8abc
Note: UCr – urinary creatinine, TBARS – thiobarbituric acid reactive 
substances. 
ap < 0,001 vs SHAM.
bp < 0,001 vs SHAM + Statin.
cp < 0,001 vs Sepse.
Data show mean ± standard deviation.
Severity of AKI and survival curve
Figure 1 shows the classification of the severity of AKI 
using the serum creatinine variation (Figure 1A) for the 
various groups. In the study, it was found that the SHAM 
and SHAM + Statin groups had serum creatinine values 
that were considered reference of normality, so these 
animals were classified as no AKI and showed a survival 
rate of 100%.
According to the AKIN criteria for classification of seve-
rity of AKI, the animals of the Sepsis group were stratified 
in stages AKIN 2 and AKIN 3. It was found that 75% of the 
animals in the Sepsis +Statin group were classified as AKIN 
stage 1, and 15% as AKIN stage 2, while 85% of animals 
with sepsis were classified as AKIN 2 and 15% as AKIN 3.
 The adapted survival curve of Kaplan-Meier (Figu-
re 1B) showed a survival rate of 100% for animals in the 
SHAM and SHAM + Statin groups. The animals submitted 
to CPL showed a survival rate of 62% and the preconditio-
ning with simvastatin determined the rise of 80% in the 
survival rate of animals with sepsis.
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Figure 1– Stages of severity of AKI and survival curve - São Paulo, 2013
diScUSSion
The present study demonstrated that preconditio-
ning with simvastatin in rats with sepsis-induced AKI 
attenuated the renal dysfunction, increased GFR and 
decreased the release of oxidative metabolites, sho-
wing favorable impact on the severity of AKI and survi-
val of animals.
The results of this study reaffirmed the accuracy of 
the AKI model, since animals evolved with physiological 
parameters characteristic of sepsis. They showed a reduc-
tion in body temperature, increased rate of blood gluco-
se and the presence of microorganisms in the culture of 
peritoneal fluid. According to the definition of the Inter-
national Sepsis Definitions Conference, held in 2001, the 
diagnosis of sepsis is suggested by primary nonspecific cli-
nical findings, such as fever or hypothermia, tachycardia, 
tachypnea, and hypotension. In clinical, the laboratory 
findings revealed leukocytosis or leukopenia, hyperglyce-
mia and hyperlactatemia. Subsequently, the syndrome is 
confirmed by isolation of the etiologic agent in cultures of 
different biological materials(20). 
According to the current guidelines of the Surviving 
Sepsis Campaign, in face of the diagnosis, the intravenous 
fluid resuscitation is recommended as an immediate in-
tervention, as well as vasoactive drugs administration, 
oxygen delivery and, when necessary, mechanical ventila-
tion. These measures positively affect the mortality rates 
in patients with sepsis(21).
In this study, all animals received fluid resuscitation 
with sodium chloride 0.9%. The hyperhydration was es-
sential for keeping the animals subjected to CPL, since the 
model reproduces a serious medical condition, which ex-
plains the high mortality of animals(8).
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The first manifestation in response to the severe 
sepsis is the reduction of oxygen to the tissues due to 
microvascular thrombosis and hypotension. In parallel, 
hyperglycemia occurs with high prevalence in patients 
with severe sepsis(21). The stress hyperglycemia, or the 
hyperglycemia condition displayed by the animals sub-
jected to CPL is caused by excessive glucose production 
by liver cells and increased insulin resistance. There are 
evidences that hyperglycemia is a physiological and be-
neficial response of cells, and frequently it is well tole-
rated by the organism. Therefore, hyperglycemia must 
be treated only when the renal excretion of glucose re-
sults in osmotic diuresis and consequent hypovolemia 
of the patient(22). 
In kidneys, the dysfunction of the microvasculature in-
creases capillary permeability and reduces the RBF, with 
disproportionate increase of the vasodilatory action on 
the afferent arteriole compared to the efferent. The re-
duction in pressure in the afferent arteriole reduces the 
intraglomerular pressure gradient, decreasing the GFR(7), 
with consequent oliguria and avid sodium absorption by 
the tubuloglomerular feedback mechanism(7-8). In this stu-
dy, the decline in GFR, with reduced creatinine clearance 
and decreased urine flow characterized the oliguric AKI in 
animals in the Sepsis group.
Additionally, the Sepsis group showed increased oxi-
dative metabolites in urine in the group submitted to the 
CPL, confirming the generation of ROS through analysis 
of urinary peroxides and TBARS. The cellular hypoxia and 
the interaction between the microorganism and the host 
immune system contribute to the formation of ROS, with 
subsequent oxidative and kidney damage(5-7).
The AKI is a disorder that involves clinical manifes-
tations, which may present with minimal change in se-
rum creatinine, progressing to anuria and subsequent 
renal failure. Epidemiological studies have shown an 
association between AKI and increased mortality rates, 
particularly for patients in need of renal replacement 
therapy (dialysis)(1).
In a current approach, the diagnostic criteria involving 
the evaluation of urinary flow and serum creatinine are 
used to identify the stage of renal impairment(1,8). 
In the present study, the severity of AKI was classified 
according to the AKIN criteria, using the value of serum 
creatinine. The results showed that the Sepsis group had 
greater severity of AKI, considering that 85% of the ani-
mals were stratified in AKIN stage 2 and 15% in AKIN stage 
3. The mortality rate among the Sepsis animals was 38%. 
The same results were observed in a study(9) of animal 
model, in which the mortality increase in the groups was 
related to the severity of AKI, similar to what was obser-
ved in this study(19).
One factor that positively interferes in the treat-
ment of sepsis is the prevention of multiple organ 
dysfunction, i.e., the investigations focused on secon-
dary reactions for reducing ROS generation, or inhibi-
ting the anticoagulation cascade, show promising re-
sults for protection of organs, particularly the kidney 
and lungs(4-5).
Among these possibilities, there are the statins, which 
belong to the class of drugs with lipid-lowering action, wi-
th the ability to reduce the action of the enzyme 3-hydro-
xy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, 
that reflects in the reduction of serum levels of total cho-
lesterol, low density lipid cholesterol (LDL), apolipopro-
tein B and triglyceride levels(23).
In this study, the preconditioning with simvastatin 
demonstrated a protective effect on renal function of 
animals subjected to CPL. Despite not observing impro-
vement in urine flow, simvastatin increased creatinine 
clearance, which confirmed the recovery of renal func-
tion. This probably occurred largely in response to its 
antioxidant action, which became evident due to the 
reduction of urinary peroxides and TBARS. Other expe-
rimental studies confirm these results, since the admi-
nistration of simvastatin in a cisplatin-induced nephro-
toxicity model resulted in improved renal function, with 
an increase in the level of antioxidant enzymes and re-
duction of oxidative metabolites(24). An in vivo study in 
ischemic AKI model associated with statin therapy sho-
wed a reduction of ROS and consequent improvement 
in renal function(14).
The animals induced to sepsis and treated with si-
mvastatin (75%) were classified as AKIN stage 1 for AKI 
severity, with improvement in survival rate and morta-
lity reduction for 20%. These results confirm a direct 
relationship between serum creatinine values, stage of 
severity of AKI and the mortality rate of animals with 
sepsis.
The results of this experimental study highlight and 
complement the experiences in clinical sepsis, and show 
advantages for its understanding because they enable the 
isolation of variables. It is worth noting that the sepsis-
induced AKI has important differences, such as responses 
to interventions and clinical outcomes compared to AKI 
not associated with sepsis(25).
conclUSion
The technique of CPL induced a condition of sepsis, 
evidenced by hypothermia and the increase in blood 
glucose and oliguric AKI with increased urinary excre-
tion of peroxides and TBARS in the animals. The induc-
tion of sepsis consisted in greater severity of AKI, with 
high mortality rate. The preconditioning with simvas-
tatin improved the renal function and reduced the re-
lease of oxidative metabolites in the urine of animals, 
confirming its action as an antioxidant.
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